ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 123 filers reported holding ANI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,420,143 | +10.7% | 558,372 | +2.7% | 0.01% | +22.2% |
| Q2 2023 | $29,280,264 | +38.8% | 543,942 | +2.4% | 0.01% | +28.6% |
| Q1 2023 | $21,098,813 | +99403.9% | 531,192 | +0.8% | 0.01% | +16.7% |
| Q4 2022 | $21,204 | -99.9% | 527,076 | +0.3% | 0.01% | 0.0% |
| Q3 2022 | $16,887,000 | +5.7% | 525,449 | -2.5% | 0.01% | 0.0% |
| Q2 2022 | $15,983,000 | +24.6% | 538,743 | +18.1% | 0.01% | +50.0% |
| Q1 2022 | $12,823,000 | -28.5% | 456,147 | +17.2% | 0.00% | -20.0% |
| Q4 2021 | $17,940,000 | +44.5% | 389,304 | +2.9% | 0.01% | +25.0% |
| Q3 2021 | $12,414,000 | -19.3% | 378,216 | -13.9% | 0.00% | -20.0% |
| Q2 2021 | $15,392,000 | +4.5% | 439,176 | +7.6% | 0.01% | 0.0% |
| Q1 2021 | $14,734,000 | +18.6% | 408,314 | -4.5% | 0.01% | +25.0% |
| Q4 2020 | $12,419,000 | -0.6% | 427,654 | -3.4% | 0.00% | -20.0% |
| Q3 2020 | $12,491,000 | -22.1% | 442,772 | -10.7% | 0.01% | -28.6% |
| Q2 2020 | $16,029,000 | -21.6% | 495,663 | -1.3% | 0.01% | -36.4% |
| Q1 2020 | $20,458,000 | -36.3% | 502,159 | -3.6% | 0.01% | -8.3% |
| Q4 2019 | $32,122,000 | -17.8% | 520,871 | -2.8% | 0.01% | -20.0% |
| Q3 2019 | $39,059,000 | -11.6% | 535,940 | -0.3% | 0.02% | -11.8% |
| Q2 2019 | $44,175,000 | +17.1% | 537,427 | +0.5% | 0.02% | +13.3% |
| Q1 2019 | $37,737,000 | +61.7% | 534,993 | +3.2% | 0.02% | +36.4% |
| Q4 2018 | $23,339,000 | -19.4% | 518,427 | +1.3% | 0.01% | 0.0% |
| Q3 2018 | $28,941,000 | -9.6% | 511,881 | +6.8% | 0.01% | -15.4% |
| Q2 2018 | $32,019,000 | +17.5% | 479,325 | +2.4% | 0.01% | +18.2% |
| Q1 2018 | $27,261,000 | -7.2% | 468,244 | +2.7% | 0.01% | -8.3% |
| Q4 2017 | $29,377,000 | +31.8% | 455,817 | +7.3% | 0.01% | +20.0% |
| Q3 2017 | $22,297,000 | +40.4% | 424,797 | +25.2% | 0.01% | +42.9% |
| Q2 2017 | $15,878,000 | +80.7% | 339,268 | +91.1% | 0.01% | +75.0% |
| Q1 2017 | $8,789,000 | +58.4% | 177,525 | +94.0% | 0.00% | +33.3% |
| Q4 2016 | $5,548,000 | +74.3% | 91,514 | +90.7% | 0.00% | +50.0% |
| Q3 2016 | $3,183,000 | +297.9% | 47,980 | +234.9% | 0.00% | – |
| Q2 2016 | $800,000 | +70.6% | 14,326 | +2.9% | 0.00% | – |
| Q1 2016 | $469,000 | -25.3% | 13,923 | 0.0% | 0.00% | – |
| Q4 2015 | $628,000 | +14.2% | 13,923 | 0.0% | 0.00% | – |
| Q3 2015 | $550,000 | -36.3% | 13,923 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $864,000 | +151.9% | 13,923 | +153.9% | 0.00% | – |
| Q1 2015 | $343,000 | +11.0% | 5,483 | 0.0% | 0.00% | – |
| Q4 2014 | $309,000 | +14.4% | 5,483 | -42.5% | 0.00% | – |
| Q3 2014 | $270,000 | -17.7% | 9,530 | 0.0% | 0.00% | – |
| Q2 2014 | $328,000 | +7.9% | 9,530 | -1.8% | 0.00% | – |
| Q1 2014 | $304,000 | +55.9% | 9,705 | 0.0% | 0.00% | – |
| Q4 2013 | $195,000 | +105.3% | 9,705 | 0.0% | 0.00% | – |
| Q3 2013 | $95,000 | – | 9,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |